Brown Brothers Harriman & Co’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.46M | Sell |
11,152
-1,868
| -14% | -$517K | 0.01% | 319 |
|
|
2026
Q1 | $3.85M | Buy |
13,020
+2,893
| +29% | +$859K | 0.02% | 226 |
|
|
2025
Q4 | $2.77M | Buy |
10,127
+969
| +11% | +$263K | 0.02% | 232 |
|
|
2025
Q3 | $2.47M | Buy |
9,158
+369
| +4% | +$100K | 0.02% | 231 |
|
|
2025
Q2 | $2.42M | Buy |
8,789
+678
| +8% | +$184K | 0.02% | 223 |
|
|
2025
Q1 | $2.15M | Buy |
8,111
+138
| +2% | +$34K | 0.02% | 219 |
|
|
2024
Q4 | $1.85M | Sell |
7,973
-788
| -9% | -$181K | 0.01% | 232 |
|
|
2024
Q3 | $1.93M | Sell |
8,761
-2,785
| -24% | -$576K | 0.01% | 223 |
|
|
2024
Q2 | $2.27M | Buy |
11,546
+1,736
| +18% | +$359K | 0.02% | 194 |
|
|
2024
Q1 | $2.11M | Sell |
9,810
-1,977
| -17% | -$415K | 0.02% | 195 |
|
|
2023
Q4 | $2.48M | Buy |
11,787
+1,536
| +15% | +$328K | 0.02% | 181 |
|
|
2023
Q3 | $2.05M | Buy |
10,251
+2,663
| +35% | +$529K | 0.02% | 185 |
|
|
2023
Q2 | $1.41M | Buy |
7,588
+255
| +3% | +$47.1K | 0.01% | 208 |
|
|
2023
Q1 | $1.4M | Buy |
7,333
+909
| +14% | +$164K | 0.01% | 215 |
|
|
2022
Q4 | $1.08M | Sell |
6,424
-674
| -9% | -$117K | 0.01% | 216 |
|
|
2022
Q3 | $1.26M | Buy |
7,098
+339
| +5% | +$67K | 0.01% | 194 |
|
|
2022
Q2 | $1.38M | Sell |
6,759
-879
| -12% | -$186K | 0.01% | 183 |
|
|
2022
Q1 | $1.82M | Buy |
7,638
+496
| +7% | +$116K | 0.01% | 176 |
|
|
2021
Q4 | $1.63M | Buy |
7,142
+503
| +8% | +$111K | 0.01% | 190 |
|
|
2021
Q3 | $1.28M | Buy |
6,639
+5,695
| +603% | +$1.15M | 0.01% | 200 |
|
|
2021
Q2 | $201K | Sell |
944
-15
| -2% | -$3.17K | ﹤0.01% | 439 |
|
|
2021
Q1 | $196K | Buy |
959
+794
| +481% | +$156K | ﹤0.01% | 417 |
|
|
2020
Q4 | $30K | Sell |
165
-4
| -2% | -$680 | ﹤0.01% | 740 |
|
|
2020
Q3 | $28K | Sell |
169
-145
| -46% | -$24.4K | ﹤0.01% | 643 |
|
|
2020
Q2 | $51K | Buy |
314
+13
| +4% | +$2.33K | ﹤0.01% | 574 |
|
|
2020
Q1 | $52K | Sell |
301
-818
| -73% | -$163K | ﹤0.01% | 528 |
|
|
2019
Q4 | $225K | Buy |
1,119
+415
| +59% | +$85.1K | ﹤0.01% | 448 |
|
|
2019
Q3 | $149K | Buy |
704
+313
| +80% | +$65.4K | ﹤0.01% | 475 |
|
|
2019
Q2 | $76K | Buy |
391
+329
| +531% | +$60.7K | ﹤0.01% | 534 |
|
|
2019
Q1 | $10K | Sell |
62
-94
| -60% | -$16.6K | ﹤0.01% | 835 |
|
|
2018
Q4 | $29K | Buy |
156
+147
| +1,633% | +$27.1K | ﹤0.01% | 583 |
|
|
2018
Q3 | $2K | Sell |
9
-33
| -79% | -$5.56K | ﹤0.01% | 782 |
|
|
2018
Q2 | $7K | Hold |
42
| – | – | ﹤0.01% | 702 |
|
|
2018
Q1 | $7K | Sell |
42
-736
| -95% | -$117K | ﹤0.01% | 691 |
|
|
2017
Q4 | $114K | Buy |
778
+580
| +293% | +$82.6K | ﹤0.01% | 417 |
|
|
2017
Q3 | $27K | Buy |
198
+160
| +421% | +$20.2K | ﹤0.01% | 545 |
|
|
2017
Q2 | $5K | Sell |
38
-38
| -50% | -$4.54K | ﹤0.01% | 698 |
|
|
2017
Q1 | $9K | Buy |
+76
| New | +$9.14K | ﹤0.01% | 661 |
|
|
2016
Q2 | – | Sell |
-82
| Closed | -$8K | – | 834 |
|
|
2016
Q1 | $8K | Sell |
82
-390
| -83% | -$35.5K | ﹤0.01% | 577 |
|
|
2015
Q4 | $43K | Buy |
472
+130
| +38% | +$12.2K | ﹤0.01% | 484 |
|
|
2015
Q3 | $32K | Buy |
+342
| New | +$32.5K | ﹤0.01% | 549 |
|
|
2015
Q1 | – | Sell |
-509
| Closed | -$45K | – | 773 |
|
|
2014
Q4 | $45K | Buy |
+509
| New | +$43.1K | ﹤0.01% | 527 |
|
|
2014
Q3 | – | Sell |
-19,871
| Closed | -$1.41M | – | 761 |
|
|
2014
Q2 | $1.41M | Buy |
19,871
+7,992
| +67% | +$563K | 0.01% | 185 |
|
|
2014
Q1 | $879K | Sell |
11,879
-9,171
| -44% | -$692K | ﹤0.01% | 189 |
|
|
2013
Q4 | $1.65M | Buy |
21,050
+10,525
| +100% | +$824K | ﹤0.01% | 197 |
|
|
2013
Q3 | $778K | Sell |
10,525
-17,280
| -62% | -$1.27M | ﹤0.01% | 195 |
|
|
2013
Q2 | $2.11M | Buy |
+27,805
| New | +$1.82M | 0.01% | 165 |
|
Other funds holding CME
Brown Brothers Harriman & Co's CME Position: Q2 2026 in Review
Brown Brothers Harriman & Co reduced its CME Group (CME) stake by 14% in Q2 2026, selling an estimated $517K and leaving 11,152 shares worth $2.46M. The position accounts for 0.01% of the portfolio, ranked #319.
Brown Brothers Harriman & Co first reported a position in CME in Q2 2013 and has held it in 47 quarters since. The position peaked at $3.85M in Q1 2026. 1,701 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Brown Brothers Harriman & Co held 11,152 shares of CME Group worth $2.46M as of Q2 2026.
- Brown Brothers Harriman & Co sold 1,868 CME Group shares in Q2 2026, an estimated $517K.
- CME Group made up 0.01% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #319 holding.
- Brown Brothers Harriman & Co first reported a position in CME Group in Q2 2013 and has held it in 47 quarters since.
- Brown Brothers Harriman & Co's CME Group position peaked at $3.85M in Q1 2026.
- 1,701 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.